Search results
Results from the Health.Zone Content Network
Sept. 29, 2023 – The FDA has approved a new drug to treat major depressive disorder in adults that does not have common side effects found with other drugs for depression, the Houston-based drug ...
Results from the clinical trial results showed: Participants who received tirzepatide for the 176-week period had an overall reduction in risk of. progression to type 2 diabetes of 94%. Those who ...
Top doctors in , Daily health news from WebMD's team of award-winning journalists. WebMD is the destination for trustworthy and timely medical and health news and information.
2 min read. Aug. 21, 2024 – The FDA has approved a new initial treatment for advanced non-small-cell lung cancer after clinical trials showed patients lived longer without disease progression ...
In fact, the diabetes medication Mounjaro has been on the Food and Drug Administration’s shortage list since late 2022, while Zepbound, a drug approved for weight loss, appeared on the list in ...
Another pharmaceutical company is voluntarily recalling its blood pressure medication — the latest development in a long list of recalls that began more than 3 years ago. On Thursday, officials ...
August 6, 2024 at 10:24 PM. (Reuters) -Two more doses of Novo Nordisk's weight-loss drug, Wegovy, is now available, the U.S. Food and Drug Administration's updated shortages list showed on Tuesday ...
September 20, 2024 at 12:09 PM. Rich Pedroncelli/AP. Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S ...